• OPEN AN ACCOUNT
Indian Indices
Sensex
83,627.69 -250.48
( -0.30%)
Global Indices
Nasdaq
49,609.72 84.64
(0.17%)
Dow Jones
6,998.08 10.80
(0.15%)
Hang Seng
53,586.32 1,646.43
(3.17%)
Nikkei 225
10,138.60 -2.10
(-0.02%)
Forex
USD-INR
90.22 0.30
(0.34%)
EUR-INR
104.95 0.05
(0.04%)
GBP-INR
120.87 0.01
(0.01%)
JPY-INR
0.57 0.00
(-0.40%)

EQUITY - MARKET SCREENER

Rajnish Wellness Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
541601
INE685Z01033
1.074797
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
0
53.81
EPS(TTM)
Face Value()
Div & Yield %
0
1
0
 

j l morison (india) ltd
Ashok Leyland gains after November sales jump 29% YoY to 18,272 units
Dec 01,2025
The company’s total domestic sales jumped 32% year-on-year to 16,491 units in November 2025.

Domestic sales of medium and heavy commercial vehicles (M&HCV) increased 29% to 10,238 units, while light commercial vehicle (LCV) sales grew 37% to 6,253 units in November 2025 compared to the same month last year.

Ashok Leyland is engaged in the manufacture and sale of a wide range of commercial vehicles. The company also manufactures engines for industrial and marine applications, forgings, and castings.

Ashok Leyland reported a marginal rise in standalone net profit to Rs 771.06 crore in Q2 FY26, compared to Rs 770.10 crore posted in Q2 FY25. Revenue from operations jumped 9.34% year-on-year (YoY) to Rs 9,588.18 crore for the quarter ended 30 September 2025.